JPRN-jRCT1080220348
Unknown
Phase 4
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Long-Term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease as Measured by Intravascular Ultrasonography
AstraZeneca/Shionogi0 sitesJanuary 31, 2007
ConditionsHypercholesteremia
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Hypercholesteremia
- Sponsor
- AstraZeneca/Shionogi
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Ages Eligible for Study: 20 Years \- 75 Years
- •Genders Eligible for Study: Both
- •Inclusion Criteria:
- •\- Signed written informed consent,
- •\- 20 to 75 years old,
- •\- Plan to undergo coronary angiography (CAG) or PCI and LDL\-C \= 140 mg/dL (untreated patients) or LDL\-C \=100 mg/dL (treated patients
Exclusion Criteria
- •\- Acute myocardial infarction within 72 hours after the onset,
- •\- Heart failure of NYHA Class III or above,
- •\- Serious arrhythmia,
- •\- Being treated with LDL\-apheresis
- •\- History of serious reaction or hypersensitivity to other HMG\-CoA reductase inhibitors.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The evaluation of the efficacy and the safety of rikkunshito on anorexia in Parkinson's disease patientsJPRN-UMIN000009626Saitama Medical Center,Saitama Medical University20
Recruiting
Not Applicable
The evaluation of the efficacy and the safety of rikkunshito on anorexia in elderly dementia patientsElderly dementia patientsJPRN-UMIN000011198Juntendo Tokyo Koto Geriatric Medical Center, Juntendo University School of Medicine20
Recruiting
Phase 1
The safety and efficacy of robotic hepatectomyJPRN-jRCT1030210666Saiura Akio10
Completed
Not Applicable
Prospective Randomized Trial of the Effects of Rosuvastatin on the Progression of Stenosis in Adult Patients with Congenital Aortic StenosisISRCTN56552248Erasmus Medical Center, Department of Cardiology (Netherlands)180
Completed
Not Applicable
A pilot study to evaluate efficacy and safety of resveratrol for muscular dystrophy.Duchenne muscular dystrophy, Becker muscular dystrophy, Fukuyama congenital muscular dystrophyJPRN-UMIN000014836Sapporo Medical University10